companydata.dkcompanydata.dk
SearchPricingAPI
companydata.dkcompanydata.dk

Free company lookup with financials, ownership and key figures for all Danish companies.

Overview

  • Municipalities
  • Postal codes
  • Industries
  • Countries
  • Top 100 companies
  • Top lists
  • Business news
  • Check company
  • Find owner
  • Financial data
  • Credit rating
  • Credit report
  • Background check

Links

  • Search
  • Pricing
  • Company profile
  • Monitoring
  • Lead List Generator
  • CVR Enrichment
  • Network search
  • Statstidende
  • Guides
  • Glossary
  • Compare alternatives

Integrations

  • API
  • MCP-server
  • Claude
  • ChatGPT
  • Perplexity
  • Mistral Le Chat
  • Gemini
  • Zapier
  • Dinero
  • e-conomic

Who it's for

  • For accountants
  • For investors
  • For sales teams
  • For lawyers
  • For journalists

Legal

  • Privacy Policy
  • Terms of Service
  • Information Letter
  • Contact

© 2026 companydata.dk

GlyProVac ApS

CVR: 39724758

Growing 109% p.a.Micro companyEstablished (8 yrs)Loss-making
Active
Own this company?

About GlyProVac ApS

GlyProVac ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Anders Boysen and Ann Zahle Andersen. The company's owners include Bente Kristiansen, Rossi Finans ApS and I/S Rødeledsvej. The company has 3 employees. In 2025, the company reported a gross profit of DKK -2,128,863 and a net result of DKK -5,168,999 compared with DKK -3,014,952 the year before. Equity amounted to DKK -831,720.

Your company? Claim the profile and show your logo, website and social channels — for free.

Claim this profile

Overview

Company type
APS
Anpartsselskab
Address
Rørhatten 4, 5220 Odense SØ
ODENSE
5220 Odense SØ
Find nearby companies
Founded
3.7.2018

Details

Industry
Fremstilling af farmaceutiske præparater
Code: 212000
Employees
3 employees
1 FTE
(2018)
Capital
155.104 kr.

Purpose

Selskabets formål er udvikle, kommercialisere, fremstille og sælge bakterielle vacciner.

Location

Google Maps|Apple Maps|OpenStreetMap

Financials

YearGross ProfitProfit/LossTotal AssetsEquityEmployeesReport
2025-2.1 mio.-5.2 mio.4.6 mio.-832 t.6
2024-577 t.-3 mio.4.4 mio.-654 t.5
2023-815 t.-2.9 mio.5.5 mio.852 t.4
20221.3 mio.-633 t.12.2 mio.5 mio.4
2021993 t.-487 t.9.5 mio.2.4 mio.3
20201.1 mio.-699 t.3.7 mio.672 t.4
2019145 t.-918 t.2.6 mio.1.4 mio.2

How creditworthy is GlyProVac ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Industry Benchmarks

View industry report

Compared to 129 companies in Fremstilling af farmaceutiske præparater

Employees
Company6
Industry median12
50% below
Equity ratio
Company-17.9%
Industry median61.0%
100% below

Comparison is based on industry median values

Ownership

Owners
Rossi Finans ApS
CVR: 36932295
10-14,99%
I/S Rødeledsvej
CVR: 38873520
5-9,99%
GlycoPharma Holding ApS
CVR: 39691558
33,33-49,99%
GlyProVac ApS
CVR: 39724758

Management

Directors

Anders Boysen(ADM. DIR.)
Ann Zahle Andersen(DIREKTØR)

Board

Ann Zahle Andersen(FORMAND)
Allan Rosetzsky(BESTYRELSESMEDLEM)
Kirsten Winther(BESTYRELSESMEDLEM)
Willem Adriaan de Jongh(BESTYRELSESMEDLEM)

PEP screening

Screen owners and management against the Danish FSA's official PEP lists

Founders

GlycoPharma Holding ApS

Production units (1)

GlyProVac ApS
P-no: 1023796054
Rørhatten 4, 5220, Odense SØ
Fremstilling af farmaceutiske præparater
3 employees

Is this your company?

Free

Claim this page to add your logo and social links. Free to get started.

  • Verified badge on your profile
  • Upload your logo
  • Links to your website and social channels

History

31 events
2026
Ann Zahle Andersen joins the board of GlyProVac ApSJun 11, 2026

As of June 11, 2026, Ann Zahle Andersen has joined the board of directors of GlyProVac ApS.

Ann Zahle Andersen leaves the board of GlyProVac ApSJun 10, 2026

As of June 10, 2026, Ann Zahle Andersen has left the board of directors of GlyProVac ApS.

Tommi Petteri Kainu leaves the board of GlyProVac ApSMay 19, 2026

As of May 19, 2026, Tommi Petteri Kainu has left the board of directors of GlyProVac ApS.

Bente Kristiansen registered as owner of GlyProVac ApSMay 1, 2026

As of May 1, 2026, Bente Kristiansen is registered as an owner of GlyProVac ApS with an ownership share of 10%.

2025
GlyProVac ApS: The 2025 annual report is outDec 29, 2025

GlyProVac ApS has published its annual report for 2025. Gross profit came to DKK -2,128,863, and the net result was DKK -5,168,999.

2024
GlyProVac ApS: The 2024 annual report is outDec 19, 2024

GlyProVac ApS has published its annual report for 2024. Gross profit came to DKK -577,426, and the net result was DKK -3,014,952.

2023
GlyProVac ApS: The 2023 annual report is outOct 6, 2023

GlyProVac ApS has published its annual report for 2023. Gross profit came to DKK -814,748, and the net result was DKK -2,871,688.

Kirsten Winther joins the board of GlyProVac ApSOct 5, 2023

As of October 5, 2023, Kirsten Winther has joined the board of directors of GlyProVac ApS.

Tommi Petteri Kainu joins the board of GlyProVac ApSOct 5, 2023

As of October 5, 2023, Tommi Petteri Kainu has joined the board of directors of GlyProVac ApS.

Kirsten Winther leaves the board of GlyProVac ApSOct 4, 2023

As of October 4, 2023, Kirsten Winther has left the board of directors of GlyProVac ApS.

Tommi Petteri Kainu leaves the board of GlyProVac ApSOct 4, 2023

As of October 4, 2023, Tommi Petteri Kainu has left the board of directors of GlyProVac ApS.

Rossi Finans ApS registered as owner of GlyProVac ApSSep 28, 2023

As of September 28, 2023, Rossi Finans ApS is registered as an owner of GlyProVac ApS with an ownership share of 10%.

2022
GlyProVac ApS: The 2022 annual report is outNov 8, 2022

GlyProVac ApS has published its annual report for 2022. Gross profit came to DKK 1,321,135, and the net result was DKK -633,455.

Allan Rosetzsky joins the board of GlyProVac ApSMar 1, 2022

As of March 1, 2022, Allan Rosetzsky has joined the board of directors of GlyProVac ApS.

Anders Boysen leaves the board of GlyProVac ApSMar 1, 2022

As of March 1, 2022, Anders Boysen has left the board of directors of GlyProVac ApS.

I/S Rødeledsvej registered as owner of GlyProVac ApSMar 1, 2022

As of March 1, 2022, I/S Rødeledsvej is registered as an owner of GlyProVac ApS with an ownership share of 5%.

GlycoPharma Holding ApS registered as owner of GlyProVac ApSMar 1, 2022

As of March 1, 2022, GlycoPharma Holding ApS is registered as an owner of GlyProVac ApS with an ownership share of 33%.

Tommi Petteri Kainu joins the board of GlyProVac ApSJan 1, 2022

As of January 1, 2022, Tommi Petteri Kainu has joined the board of directors of GlyProVac ApS.

2021
GlyProVac ApS: The 2021 annual report is outNov 30, 2021

GlyProVac ApS has published its annual report for 2021. Gross profit came to DKK 993,453, and the net result was DKK -487,049.

Willem Adriaan de Jongh joins the board of GlyProVac ApSAug 29, 2021

As of August 29, 2021, Willem Adriaan de Jongh has joined the board of directors of GlyProVac ApS.

2020
GlyProVac ApS: The 2020 annual report is outNov 3, 2020

GlyProVac ApS has published its annual report for 2020. Gross profit came to DKK 1,050,949, and the net result was DKK -698,589.

2019
GlyProVac ApS: The 2019 annual report is outNov 8, 2019

GlyProVac ApS has published its annual report for 2019. Gross profit came to DKK 145,314, and the net result was DKK -917,733.

Kirsten Winther joins the board of GlyProVac ApSJan 29, 2019

As of January 29, 2019, Kirsten Winther has joined the board of directors of GlyProVac ApS.

Peter Smedegaard leaves the board of GlyProVac ApSJan 25, 2019

As of January 25, 2019, Peter Smedegaard has left the board of directors of GlyProVac ApS.

2018
GlyProVac ApS appoints new auditorJul 3, 2018

As of July 3, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GlyProVac ApS.

Peter Smedegaard joins the board of GlyProVac ApSJul 3, 2018

As of July 3, 2018, Peter Smedegaard has joined the board of directors of GlyProVac ApS.

Anders Boysen joins the board of GlyProVac ApSJul 3, 2018

As of July 3, 2018, Anders Boysen has joined the board of directors of GlyProVac ApS.

Ann Zahle Andersen joins the board of GlyProVac ApSJul 3, 2018

As of July 3, 2018, Ann Zahle Andersen has joined the board of directors of GlyProVac ApS.

Anders Boysen joins GlyProVac ApS as adm. dir.Jul 3, 2018

As of July 3, 2018, Anders Boysen is registered as adm. dir. of GlyProVac ApS.

Ann Zahle Andersen joins GlyProVac ApS as directorJul 3, 2018

As of July 3, 2018, Ann Zahle Andersen is registered as director of GlyProVac ApS.

GlyProVac ApS is foundedJul 3, 2018

GlyProVac ApS was founded on July 3, 2018.

Similar companies

Companies in the same industry and area

Lucia Care ApS

CVR 42499781

Fremstilling af farmaceutiske præparaterODENSE

RhomeoX ApS

CVR 43458078

Fremstilling af farmaceutiske præparaterODENSE